These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28185163)

  • 21. Patient selection for cardiac resynchronization therapy: from the Council on Clinical Cardiology Subcommittee on Electrocardiography and Arrhythmias and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society.
    Strickberger SA; Conti J; Daoud EG; Havranek E; Mehra MR; Piña IL; Young J; ;
    Circulation; 2005 Apr; 111(16):2146-50. PubMed ID: 15851622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical trials in hospitalized heart failure patients: targeting interventions to optimal phenotypic subpopulations.
    Vaduganathan M; Butler J; Roessig L; Fonarow GC; Greene SJ; Metra M; Cotter G; Kupfer S; Zalewski A; Sato N; Filippatos G; Gheorghiade M
    Heart Fail Rev; 2015 Jul; 20(4):393-400. PubMed ID: 25894076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liberal versus restricted fluid administration in heart failure patients. A systematic review and meta-analysis of randomized trials.
    Li Y; Fu B; Qian X
    Int Heart J; 2015; 56(2):192-5. PubMed ID: 25740394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What Are Effective Program Characteristics of Self-Management Interventions in Patients With Heart Failure? An Individual Patient Data Meta-analysis.
    Jonkman NH; Westland H; Groenwold RH; Ågren S; Anguita M; Blue L; Bruggink-André de la Porte PW; DeWalt DA; Hebert PL; Heisler M; Jaarsma T; Kempen GI; Leventhal ME; Lok DJ; Mårtensson J; Muñiz J; Otsu H; Peters-Klimm F; Rich MW; Riegel B; Strömberg A; Tsuyuki RT; Trappenburg JC; Schuurmans MJ; Hoes AW
    J Card Fail; 2016 Nov; 22(11):861-871. PubMed ID: 27374838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study.
    Dokainish H; Teo K; Zhu J; Roy A; AlHabib KF; ElSayed A; Palileo-Villaneuva L; Lopez-Jaramillo P; Karaye K; Yusoff K; Orlandini A; Sliwa K; Mondo C; Lanas F; Prabhakaran D; Badr A; Elmaghawry M; Damasceno A; Tibazarwa K; Belley-Cote E; Balasubramanian K; Islam S; Yacoub MH; Huffman MD; Harkness K; Grinvalds A; McKelvie R; Bangdiwala SI; Yusuf S;
    Lancet Glob Health; 2017 Jul; 5(7):e665-e672. PubMed ID: 28476564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using Natriuretic Peptides for Selection of Patients in Acute Heart Failure Clinical Trials.
    Smith SA; Mentz RJ; Roessig L; Mebazza A; Longrois D; Gheorghiade M; Pitt B; Zannad F; Butler J; Abraham WT
    Am J Cardiol; 2015 Oct; 116(8):1304-10. PubMed ID: 26282727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Designing Future Clinical Trials in Heart Failure With Preserved Ejection Fraction: Lessons From TOPCAT.
    Patel RB; Shah SJ; Fonarow GC; Butler J; Vaduganathan M
    Curr Heart Fail Rep; 2017 Aug; 14(4):217-222. PubMed ID: 28647918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Run-in Periods in Randomized Clinical Trials.
    Schechtman KB
    J Card Fail; 2017 Sep; 23(9):700-701. PubMed ID: 28757151
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of limiting fluid intake on clinical and laboratory outcomes in patients with heart failure. Results of a meta-analysis of randomized controlled trials.
    De Vecchis R; Baldi C; Cioppa C; Giasi A; Fusco A
    Herz; 2016 Feb; 41(1):63-75. PubMed ID: 26292805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness and Factors Determining the Success of Management Programs for Patients With Heart Failure: A Systematic Review and Meta-analysis.
    Oyanguren J; Latorre García PM; Torcal Laguna J; Lekuona Goya I; Rubio Martín S; Maull Lafuente E; Grandes G
    Rev Esp Cardiol (Engl Ed); 2016 Oct; 69(10):900-914. PubMed ID: 27692124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.
    Wedel H; Demets D; Deedwania P; Fagerberg B; Goldstein S; Gottlieb S; Hjalmarson A; Kjekshus J; Waagstein F; Wikstrand J;
    Am Heart J; 2001 Sep; 142(3):502-11. PubMed ID: 11526365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global differences in patient characteristics, case management and outcomes in intracerebral hemorrhage: the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial.
    Christensen MC; Broderick J; Vincent C; Morris S; Steiner T
    Cerebrovasc Dis; 2009; 28(1):55-64. PubMed ID: 19468216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pentoxifylline for heart failure: a systematic review.
    Batchelder K; Mayosi BM
    S Afr Med J; 2005 Mar; 95(3):171-5. PubMed ID: 15832667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of frailty profile for targeting older heart failure patients in disease management programs: a cost-effectiveness, pilot study.
    Pulignano G; Del Sindaco D; Di Lenarda A; Tarantini L; Cioffi G; Gregori D; Tinti MD; Monzo L; Minardi G
    J Cardiovasc Med (Hagerstown); 2010 Oct; 11(10):739-47. PubMed ID: 20736784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spectrum of epidemiological and clinical findings in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review.
    Vaduganathan M; Michel A; Hall K; Mulligan C; Nodari S; Shah SJ; Senni M; Triggiani M; Butler J; Gheorghiade M
    Eur J Heart Fail; 2016 Jan; 18(1):54-65. PubMed ID: 26634799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac resynchronization therapy: expanding clinical indications and refining patient selection.
    Nery PB; Keren A; Birnie DH
    Curr Opin Cardiol; 2012 Mar; 27(2):137-42. PubMed ID: 22233979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Key issues in end point selection for heart failure trials: composite end points.
    Neaton JD; Gray G; Zuckerman BD; Konstam MA
    J Card Fail; 2005 Oct; 11(8):567-75. PubMed ID: 16230258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cardiac resynchronization therapy in chronic heart failure].
    Sticherling C
    Praxis (Bern 1994); 2007 Mar; 96(11):421-2. PubMed ID: 17405535
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.